Related Experiment Video
Updated: Apr 26, 2026
07:42
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.1K
Recent research about mild cognitive impairment in China
1Diagnosis and Treatment Center of Alzheimer's Disease, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Archives of Psychiatry
|August 13, 2014
Summary
Research on mild cognitive impairment (MCI) in China shows progress in understanding its epidemiology and characteristics. Future prevention and treatment require large, multidisciplinary studies with standardized methods.
Area of Science:
- Gerontology
- Neurology
- Public Health
Background:
- China's population is aging rapidly, increasing the need for dementia and mild cognitive impairment (MCI) research.
- Mild cognitive impairment (MCI) is a critical precursor to dementia, necessitating focused study.
Purpose of the Study:
- To review and synthesize a decade of research on mild cognitive impairment (MCI) in China.
- To identify key findings and limitations in the current understanding and management of MCI.
Main Methods:
- Comprehensive literature review of studies published in the last ten years focusing on MCI in China.
- Analysis of research covering epidemiology, diagnosis, etiology, and treatment of MCI.
Main Results:
- Significant research has been conducted on MCI epidemiology, neuropsychological features, diagnosis, genetic factors, neuroimaging, and electrophysiology.
- While insights have been gained, major breakthroughs in MCI prevention and treatment remain limited.
Conclusions:
- Further progress in preventing and treating MCI necessitates large-scale, multi-disciplinary, prospective studies.
- Standardized assessment and monitoring methods are crucial for advancing MCI research and clinical practice.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
911
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
911
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:30Dementia
681
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
681
01:29Alzheimer Disease l: Introduction
19
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29